Signs and the Path to a Clear Diagnosis
At a Glance
Alpha-mannosidosis is diagnosed by matching symptoms such as hearing loss, repeated infections, developmental delay, and skeletal changes with enzyme testing and MAN2B1 gene testing. A urine or blood test for certain sugar chains can suggest the condition but cannot confirm it alone.
The journey to an alpha-mannosidosis diagnosis often starts with symptoms that, on their own, seem like common childhood hurdles. However, when these “puzzle pieces” are viewed together, they form a pattern that points toward a rare metabolic condition [1]. Understanding these signs and the specific tests needed for a diagnosis is the first step in moving from uncertainty to a clear plan of care.
Common Early Symptoms
Most babies with alpha-mannosidosis appear healthy at birth, and early hearing tests may even be normal [2]. Symptoms usually begin to emerge in infancy, childhood, or sometimes even into adulthood [2][3].
- Hearing and Speech: One of the most common early symptoms is hearing impairment. This can be sensorineural (involving the inner ear or nerve) or conductive (caused by chronic middle-ear disease and frequent infections) [1][4]. This frequently leads to significant speech delays [5].
- Recurrent Infections: Many experience frequent infections, particularly in the upper respiratory tract (like chronic ear infections or colds) [5][4]. This is often linked to the way the condition affects the immune system [6].
- Developmental and Motor Delay: You may notice missed milestones like walking or sitting up later than expected. Over time, difficulties with coordination or balance (ataxia) may become more noticeable [7][8].
- Physical Features: Doctors may look for “coarse” facial features, such as a prominent forehead or a flattened bridge of the nose. Other physical signs can include hernias (bulges in the groin or belly button area) and dysostosis multiplex, a specific pattern of skeletal changes visible on X-rays [9][4].
Distinguishing Alpha-Mannosidosis from “Mimics”
Alpha-mannosidosis is frequently confused with a group of similar conditions called Mucopolysaccharidoses (MPS), particularly MPS I (also known as Hurler or Scheie syndrome) [10][11].
Both conditions share features like skeletal changes, coarse facial features, and hearing loss. However, they are caused by different missing enzymes and lead to the buildup of different substances [10][11]. While MPS I involves the buildup of glycosaminoglycans (GAGs), alpha-mannosidosis involves mannose-rich oligosaccharides [11][10]. Distinguishing between them is critical because the treatments for each are very different [11].
The Diagnostic Checklist
Getting a definitive diagnosis requires a specific set of tests. Doctors use a combination of screening and confirmatory tools.
1. Screening: Oligosaccharide Testing
A doctor may start by testing urine or blood for mannose-rich oligosaccharides [1][12].
- What it tells us: High levels suggest that the body isn’t breaking down these sugars correctly [13].
- The limit: While a very useful red flag, this test is for screening only. It cannot provide a final diagnosis on its own because other rare conditions can sometimes cause similar results [13][14].
2. Confirmation: Enzyme Activity
A critical step for diagnosis is measuring the activity of the lysosomal alpha-mannosidase enzyme [1].
- The Test: This is typically done using white blood cells (leukocytes) or skin cells (fibroblasts) [15][16].
- The Result: The diagnosis is supported when enzyme activity is markedly deficient. The exact percentage depends on the laboratory assay and the tissue used [2][15].
3. Confirmation: Genetic Testing
To be absolutely certain, doctors perform genetic testing to look for mutations in the MAN2B1 gene [12].
- Biallelic Variants: For confirmation, the test generally needs to identify two disease-causing mutations, one inherited from each parent (referred to as being in trans) [12].
- Hidden Mutations: Sometimes, standard genetic tests might find only one mutation, or they might find a “variant of uncertain significance.” In these situations, specialists may need to run more advanced tests (like deletion/duplication testing) to find structural changes in the DNA or interpret complex results [12][17].
By combining these three pieces—clinical symptoms, markedly deficient enzyme activity, and genetic confirmation—your care team can provide an accurate diagnosis [1].
Common questions in this guide
What symptoms can suggest alpha-mannosidosis?
How is alpha-mannosidosis confirmed?
Can an oligosaccharide test diagnose alpha-mannosidosis by itself?
What does low alpha-mannosidase enzyme activity mean?
What happens if genetic testing finds only one MAN2B1 change?
How is alpha-mannosidosis different from MPS I?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on the symptoms, such as recurrent infections and hearing loss, how did you rule out more common conditions like MPS I?
- 2.Was the enzyme activity testing performed using leukocytes or fibroblasts, and what were the specific results?
- 3.If genetic testing only found one MAN2B1 variant or a variant of uncertain significance, what are the next steps to look for a hidden structural variant?
- 4.How do the urinary oligosaccharide levels compare to what is typically seen in alpha-mannosidosis, and how will we use this test to monitor them over time?
- 5.At what age should we begin regular screenings for specific skeletal issues like dysostosis multiplex?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Recognition of alpha-mannosidosis in paediatric and adult patients: Presentation of a diagnostic algorithm from an international working group.
Guffon N, Tylki-Szymanska A, Borgwardt L, et al.
Molecular genetics and metabolism 2019; (126(4)):470-474 doi:10.1016/j.ymgme.2019.01.024.
PMID: 30792122 - 2
Ultra-orphan lysosomal storage diseases: A cross-sectional quantitative analysis of the natural history of alpha-mannosidosis.
Zielonka M, Garbade SF, Kölker S, et al.
Journal of inherited metabolic disease 2019; (42(5)):975-983 doi:10.1002/jimd.12138.
PMID: 31222755 - 3
Delayed diagnosis and clinical course of alpha-mannosidosis: A retrospective study of 25 patients with varying severity.
Nurse JH, Hennermann JB, Curiati MA, et al.
Genetics in medicine open 2025; (3()):103465 doi:10.1016/j.gimo.2025.103465.
PMID: 41334501 - 4
Long-term outcome of patients with alpha-mannosidosis - A single center study.
Lipiński P, Różdżyńska-Świątkowska A, Iwanicka-Pronicka K, et al.
Molecular genetics and metabolism reports 2022; (30()):100826 doi:10.1016/j.ymgmr.2021.100826.
PMID: 35242565 - 5
Long-term clinical evaluation of patients with alpha-mannosidosis - A multicenter study.
Köse E, Kasapkara ÇS, İnci A, et al.
European journal of medical genetics 2024; (68()):104927 doi:10.1016/j.ejmg.2024.104927.
PMID: 38382588 - 6
Retrospective Study of Clinical and Genetic Profiles of Alpha-Mannosidosis Patients From the UAE.
Saad AK, Al-Hammadi T, Al-Ameri S, et al.
JIMD reports 2025; (66(2)):e70001 doi:10.1002/jmd2.70001.
PMID: 39926434 - 7
Cognitive profile and activities of daily living: 35 patients with alpha-mannosidosis.
Borgwardt L, Thuesen AM, Olsen KJ, et al.
Journal of inherited metabolic disease 2015; (38(6)):1119-27 doi:10.1007/s10545-015-9862-4.
PMID: 26016802 - 8
Intellectual functioning in alpha-mannosidosis.
Cathey SS, Sarasua SM, Simensen R, et al.
JIMD reports 2019; (50(1)):44-49 doi:10.1002/jmd2.12073.
PMID: 31741826 - 9
Unveiling alpha-mannosidosis in Iraqi children: A series of clinically and genetically characterized cases with novel MAN2B1 variant.
Al Tai MR, Saadi NW, Alothman MS, et al.
Molecular genetics and metabolism reports 2026; (46()):101282 doi:10.1016/j.ymgmr.2025.101282.
PMID: 41567994 - 10
Mucopolysaccharidosis Type I and α-Mannosidosis-Phenotypically Comparable but Genetically Different: Diagnostic and Therapeutic Considerations.
Venezia M, Vinci M, Colomba P, et al.
Biomedicines 2025; (13(5)) doi:10.3390/biomedicines13051199.
PMID: 40427026 - 11
Hearing impairment as an early sign of alpha-mannosidosis in children with a mild phenotype: Report of seven new cases.
Lehalle D, Colombo R, O'Grady M, et al.
American journal of medical genetics. Part A 2019; (179(9)):1756-1763 doi:10.1002/ajmg.a.61273.
PMID: 31241255 - 12
An unusual diagnosis of alpha-mannosidosis with ocular anomalies: Behind the scenes of a hidden copy number variation.
Uguen K, Redon S, Rouault K, et al.
American journal of medical genetics. Part A 2024; (194(5)):e63532 doi:10.1002/ajmg.a.63532.
PMID: 38192009 - 13
Analysis of serum oligosaccharides by UPLC-MS/MS for diagnosis and treatment monitoring of patients with alpha-mannosidosis.
Kubaski F, Cason A, Herbst ZAM, et al.
Molecular genetics and metabolism 2025; (144(3)):109042 doi:10.1016/j.ymgme.2025.109042.
PMID: 39908789 - 14
UPLC-MS/MS Analysis of Urinary Free Oligosaccharides for Lysosomal Storage Diseases: Diagnosis and Potential Treatment Monitoring.
Huang R, Cathey S, Pollard L, Wood T
Clinical chemistry 2018; (64(12)):1772-1779 doi:10.1373/clinchem.2018.289645.
PMID: 30201803 - 15
Alpha-Mannosidosis in a 3.5-Year-Old Girl: A Case Report.
Bonilla Fornes S, Mendez Perez MP, Torres Diaz M, et al.
Clinical case reports 2026; (14(8)):e73276 doi:10.1002/ccr3.73276.
PMID: 42553539 - 16
Can velmanase alfa be the next widespread potential therapy for alpha-mannosidosis?
Abdul Ghani S, Burney S, Ul Hussain H, et al.
International journal of surgery (London, England) 2023; (109(9)):2882-2885 doi:10.1097/JS9.0000000000000528.
PMID: 37352513 - 17
α-mannosidosis diagnosis in Brazilian patients with MPS-like symptoms.
Marins M, Curiati MA, Gomes CP, et al.
Orphanet journal of rare diseases 2024; (19(1)):439 doi:10.1186/s13023-024-03419-z.
PMID: 39593065
This page explains alpha-mannosidosis symptoms and diagnostic testing for informational purposes only and does not constitute medical advice. A metabolic or genetics specialist should interpret your specific results.
Get notified when new evidence is published on Alpha-mannosidosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.